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Objective
To investigate the pattern of left ventricular hypertrophy
(LVH) in Anderson Fabry Disease (AFD) using CMR.
Background
AFD is an X linked disorder of lysosomal storage that
can have various cardiac manifestations, most com-
monly resulting in LVH. Echocardiographic data on
LVH distribution emphasised concentric hypertrophy in
males and later onset in females with less hypertrophy.
However this modality is often limited in visualisation of
the left ventricular apex.
Methods
27 patients (mean age 47, 33% males, a large cohort of
female heterozygotes) with genetically proven AFD were
assessed by CMR for hypertrophy, its distribution and LGE.
Results
8 (30%) of patients had no LVH (Fig 1). Of those who
did have LVH, 4 (21%) manifested an apical only distri-
bution with 7 (37%) having Concentric Hypertrophy
with Apical Cavity Obliteration (CHACO), 7 (37%) con-
centric hypertrophy with no apical cavity obliteration
and 1 (5%) asymmetrical septal hypertrophy (ASH).
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Figure 1 Distribution of hypertrophy in AFD.
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patients (3 female) subsequently found to have hypertro-
phy on CMR, 1 (3%) of whom had an apical pattern.
LGE was seen in 12 (44%) of patients. Of these 12
patients, 6 (50%) had basal infero-lateral LGE only, with
3 (25%) having basal infero-lateral and other varying
LGE distribution. A further 3 (25%) of patients had LGE
only distributed away from the basal infero-lateral wall.
Of the 4 patients with apical hypertrophy, 2 (50%) had
basal infero-lateral wall LGE, with 1 (25%) having apical
LGE and the other no LGE.
Conclusions
This study shows that AFD can manifest in an LV apical
hypertrophy phenotype with most demonstrating apical
cavity obliteration. It may be that this has not previously
been recognised due to limitations of echocardiography
in visualisation of the LV apex. Apical as well as basal
infero-lateral LGE is also a manifestation of AFD.
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